🔍

Coral Laboratories Ltd (524506)

📊 BSE: 524506 🏢 Pharmaceuticals 📢 Latest filing: 25 Sep 2026 📝 Analysis written: 13 Nov 2025

Latest quarterly results (Q1 FY27)

In its latest reported quarter, Q1 FY27, Coral Laboratories' revenue was ₹29.6 Cr (+57.4% year on year, +11.9% on the previous quarter), and net profit ₹5.4 Cr (+110.5% year on year); the operating margin was 18.5%.

Q1 FY27 (₹ Cr)	Value	YoY vs Q1 FY26	QoQ
Revenue	₹29.6	+57.4%	+11.9%
Operating profit	₹5.5	+151.7%	-11.5%
Net profit	₹5.4	+110.5%	+3.2%
EPS (₹)	15.08	+110.3%	+3.2%
Operating margin	18.5%	—	—

Full quarterly financials → Results calendar →

📢 Recent Corporate Announcements

Coral Laboratories Approves FY26 Cost Audit Report in Form CRA-3

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 25 Sep 2026, 03:00 PM

Coral Laboratories Limited held a Board of Directors meeting on September 25, 2026, to consider and approve its Cost Audit Report in Form CRA-3 for FY 2025-26. The meeting commenced at 02:30 p.m. and concluded shortly after at 02:58 p.m. This is a routine statutory and compliance filing under Indian corporate laws. The filing carries no direct operational, structural, or financial impact on the company's Rs 204 Cr market cap or earnings profile.

Board approved the Cost Audit Report in Form CRA-3 for FY 2025-26 on September 25, 2026
Meeting duration was 28 minutes, starting at 02:30 p.m. and concluding at 02:58 p.m.
Filing executed under Regulation 30 of SEBI (LODR) Regulations, 2015

💡 Track the upcoming quarterly financial results (Q2 FY27) for operational performance updates, as this cost audit filing is purely procedural.

Coral Laboratories Sets Sept 22 Record Date for Final Dividend; 44th AGM on Sept 29, 2026

🟡 NEUTRAL ⭐ 3/10

DIVIDEND 📅 14 Aug 2026, 06:30 PM

Coral Laboratories Ltd has scheduled its 44th Annual General Meeting (AGM) for Tuesday, September 29, 2026, to be conducted via Video Conferencing / Other Audio Visual Means. The company has fixed Tuesday, September 22, 2026, as the record date for determining shareholder eligibility for the final dividend. Share transfer books and the register of members will remain closed from September 23, 2026, to September 29, 2026 (both days inclusive).

44th Annual General Meeting scheduled for September 29, 2026 at 01:00 p.m. IST
Record date for final dividend fixed as Tuesday, September 22, 2026
Book closure set from September 23, 2026 to September 29, 2026 (both days inclusive)

💡 Shareholders seeking dividend eligibility should ensure ownership prior to the record date of September 22, 2026, and track AGM outcome resolutions.

Coral Laboratories Schedules 44th Annual General Meeting for September 29, 2026

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 14 Aug 2026, 06:16 PM

Coral Laboratories Limited has announced that its 44th Annual General Meeting (AGM) will be held on Tuesday, September 29, 2026, at 01:00 p.m. IST via Video Conferencing/Other Audio Visual Means. The schedule was approved by the Board of Directors in their meeting on August 14, 2026. Detailed AGM Notice and the Annual Report will be circulated separately in due course.

44th Annual General Meeting scheduled for Tuesday, September 29, 2026
AGM to be conducted at 01:00 p.m. (IST) via Video Conferencing / OAVM
Board approval for convening the AGM was granted on August 14, 2026

💡 Track the upcoming release of the Annual Report and AGM notice for detailed disclosures on strategic direction and shareholder resolutions.

Coral Laboratories Q1 PAT Surges 110% YoY to ₹5.39 Cr; Revenue Up 57.4% to ₹29.62 Cr

🟢 POSITIVE ⭐ 7/10

EARNINGS 📅 14 Aug 2026, 06:13 PM

Coral Laboratories reported strong Q1 results for the quarter ended June 30, 2026, with revenue from operations jumping 57.4% YoY to ₹29.62 Cr compared to ₹18.82 Cr in Q1 FY26. Net profit more than doubled YoY, up 110.1% to ₹5.39 Cr from ₹2.56 Cr in the year-ago quarter, while rising 3.1% sequentially. Diluted EPS stood at ₹15.08 versus ₹7.18 in Q1 FY26. The company also announced its 44th Annual General Meeting for September 29, 2026.

Revenue from operations increased 57.39% YoY to ₹2,962.31 lakhs from ₹1,882.14 lakhs.
Net profit after tax rose 110.12% YoY to ₹538.81 lakhs compared to ₹256.43 lakhs in Q1 FY26.
Basic & Diluted EPS for the quarter expanded to ₹15.08 from ₹7.18 in Q1 FY26 and ₹14.62 in Q4 FY26.
44th AGM is scheduled for September 29, 2026, with a share transfer book closure from September 23 to September 29, 2026.

💡 Track whether the elevated revenue run-rate of ~₹29.6 Cr is maintained in subsequent quarters and observe formulation margin stability.

Coral Laboratories Sets Sept 22, 2026 as Record Date for Final Dividend & 44th AGM

🟡 NEUTRAL ⭐ 3/10

DIVIDEND 📅 14 Aug 2026, 06:06 PM

Coral Laboratories Limited has announced that its 44th Annual General Meeting (AGM) will take place on Tuesday, September 29, 2026, at 01:00 PM IST via Video Conferencing. The company has fixed Tuesday, September 22, 2026, as the Record Date to determine shareholder eligibility for the final dividend. The Register of Members and Share Transfer Books will remain closed from September 23, 2026, to September 29, 2026 (both days inclusive). This is a standard corporate action intimation following annual financial closure.

44th Annual General Meeting scheduled for Tuesday, September 29, 2026, at 1:00 PM IST
Record date for final dividend entitlement fixed as Tuesday, September 22, 2026
Book closure period set from Wednesday, September 23, 2026, to Tuesday, September 29, 2026 (both days inclusive)

💡 Investors seeking entitlement to the final dividend must hold shares as of the record date (September 22, 2026) and can track AGM proceedings on September 29, 2026.

Q1 PAT surges 110% YoY to ₹5.39 Cr; Revenue up 57% to ₹29.62 Cr

🟢 POSITIVE ⭐ 7/10

EARNINGS 📅 14 Aug 2026, 05:57 PM

Coral Laboratories reported a strong 57.4% YoY increase in revenue from operations to ₹29.62 Cr for Q1 ended June 30, 2026, compared to ₹18.82 Cr in Q1 FY26. Net profit more than doubled, surging 110.1% YoY to ₹5.39 Cr against ₹2.56 Cr in the same period last year. Operating performance remained solid, lifting EPS for the quarter to ₹15.08 from ₹7.18 YoY. The company also scheduled its 44th Annual General Meeting for September 29, 2026.

Revenue from operations grew 57.39% YoY to ₹2,962.31 lakhs (₹29.62 Cr) vs ₹1,882.14 lakhs in Q1 FY26
Net profit (PAT) increased 110.12% YoY to ₹538.81 lakhs (₹5.39 Cr) vs ₹256.43 lakhs in Q1 FY26
Basic & Diluted EPS rose to ₹15.08 for the quarter vs ₹7.18 in Q1 FY26
44th AGM scheduled for September 29, 2026, with cut-off date on September 22, 2026

💡 Track whether the quarterly revenue run-rate of ~₹29 Cr is sustained in subsequent quarters and review the upcoming Annual Report for business segment commentary.

Coral Laboratories to consider Q1 FY27 results on August 14, 2026

🟡 NEUTRAL ⭐ 3/10

BOARD_MEETING 📅 05 Aug 2026, 02:32 PM

Coral Laboratories Ltd has scheduled a board meeting for August 14, 2026, to approve standalone unaudited financial results for the quarter ended June 30, 2026. The board will also finalize the date and notice for the company's 44th Annual General Meeting (AGM). The trading window for insiders has been closed since July 1, 2026, and will remain so until 48 hours after the results are announced. This is a routine regulatory filing for the small-cap pharmaceutical company, which reported a TTM revenue of ₹86 cr.

Board meeting scheduled for August 14, 2026, to approve Q1 FY27 results
Meeting will also determine the date and time for the 44th Annual General Meeting
Trading window closure commenced on July 1, 2026, per SEBI regulations
Results pertain to the standalone unaudited performance for the quarter ended June 30, 2026

💡 Investors should monitor the results on August 14 to assess if the company can improve upon its FY26 performance, where revenue declined to ₹86 cr from ₹115 cr in FY25.

View All 524506 Announcements on Live Market Tracking →